HS
ASMB icon

HighVista Strategies’s Assembly Biosciences ASMB Stock Holding History

HighVista Strategies’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.07M Buy
+74,735
New +$2.13M 0.57% 56
2021
Q1 		– Sell
-1,239
Closed -$90K – 128
2020
Q4 		$90K Sell
1,239
-985
-44% -$116K 0.06% 96
2020
Q3 		$439K Buy
+2,224
New +$560K 0.32% 62

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

HighVista Strategies's ASMB Position: Q1 2026 in Review

HighVista Strategies opened a new position in Assembly Biosciences (ASMB) in Q1 2026: 74,735 shares worth $2.07M. The stake represents 0.57% of the portfolio and ranks #56 among its holdings. This is a return to the name: HighVista Strategies previously reported a position in ASMB as recently as Q4 2020.

HighVista Strategies first reported a position in ASMB in Q3 2020 and has held it in 3 quarters since. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

  • HighVista Strategies held 74,735 shares of Assembly Biosciences worth $2.07M as of Q1 2026.
  • Assembly Biosciences was a new HighVista Strategies position in Q1 2026.
  • Assembly Biosciences made up 0.57% of HighVista Strategies's portfolio in Q1 2026, its #56 holding.
  • HighVista Strategies first reported a position in Assembly Biosciences in Q3 2020 and has held it in 3 quarters since.
  • 75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on HighVista Strategies's 13F filing for Q1 2026, filed 15 May 2026.